Search Results 2501-2510 of 18236 for rheumatoid arthritis
... arthritis, a common hand condition. The impact of this fatty infiltration on thumb function is still unknown. Dr. Amadio plans to study it clinically. Dr ...
Tyrosine kinase inhibitors, other than Janus kinase inhibitors approved for systemic autoimmune rheumatic diseases, within 12 weeks prior to Screening. 2 ...
... Factor Analysis From 7 Academic Centers in the United States. Anesth Analg. 2021 Jan; 132 (1):130-139. View PubMed; Porter SB, Hughes AJ, Ball CT, Hex KO ...
The primary objective of this study is to determine the safety and tolerability of utilizing the insulin-like growth factor-1-methotrexate conjugate, 765IGF ...
... arthritis, Basilar skull invagination, Failed back syndrome. Show more areas of focus for Eric W. Nottmeier, M.D.. Request an appointment · Conditions treated ...
... arthritis, Basilar skull invagination, Neurofibromatosis type 2, Pancoast tumor, Failed back syndrome, Nerve irritation, Brachial plexus avulsion pain ...
Male or female subjects must be ≥18 years of age. · Subjects must have a diagnosis of SSc as defined by the 2013 American College of Rheumatology criteria/EULAR ...
... Factor Receptor 2, also known as HER2-positive breast cancer. The drug involved in this study is: -ado-trastuzumab emtansine (T-DM1). Study of Trastuzumab ...
Ankle surgery: Treatment for advanced arthritis; Arthritis rehabilitation; Assistive technology for spinal cord injury; Assistive technology therapy; Autonomic ...
Globally, peripheral artery disease tends to be undertreated, even though doctors widely recognize it as a risk factor for heart disease. PAD has become ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.